Business, energy, technology, markets and global industry news from Business News Today

IL-15

Pharma & Biotech

Can Forlong Biotechnology’s FL115 poster at ASCO 2026 move the IL-15 story from scientific promise toward clinical relevance?

Forlong Biotechnology brings FL115 to ASCO 2026 with first-in-human solid tumor data. Read why the IL-15 story could matter beyond the poster.

Read More
Pharma & Biotech

ImmunityBio’s CAR-NK cell therapy achieves 15-month remission in Waldenström lymphoma

Find out how ImmunityBio’s CD19 CAR-NK cell therapy may change treatment for Waldenström lymphoma with durable responses and no chemotherapy.

Read More